Growth factors, apoptotic cells and barx1 gene in bone and soft tissue of skeletal class III patients by Jankovska, Iveta et al.
See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/6200104
Growth factors, apoptotic cells and barx1 gene in bone and soft tissue of
skeletal class III patients







Some of the authors of this publication are also working on these related projects:

















All content following this page was uploaded by Iveta Jankovska on 27 May 2014.
The user has requested enhancement of the downloaded file.
4 0 Stomatologija, Baltic Dental and Maxillofacial Journal, 2007, Vol. 9, No. 2
Growth factors, apoptotic cells and barx1 gene in bone and
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SUMMARY
Growth factors and growth stimulating genes are main signaling molecules for growth
and development in ante– and postnatal period involved in cellular proliferation, differentia-
tion and morphogenesis of tissues and organs during embryogenesis, postnatal growth and
adulthood. The aim of this study was to evaluate TGF−β (transforming growth factor−β),
BMP2/4 (bone morphogenetic protein 2/4), FGFR1 (fibroblast growth factor receptor one),
barx1 gene and apoptosis from tissue samples of oro-maxillo-facial region in skeletal class
III patients to reveal possible morphopathogenesis of severe skeletal anomalies. The study
group included 9 patients with skeletal class III malocclusion. During orthognatic surgery
tissue samples from tuber maxillae, ramus mandibulae anterior and posterior part, as well
as gingiva from the lower jaw in region of second molar have been taken. Samples were
stained with immunohistochemistry for TGF−β, BMP2/4, FGFR1, apoptosis and barx1 gene.
We used also the routine histological staining with haematoxyline and eosine.
In tuber maxillae, ramus mandibulae anterior and posterior part staining for TGF−β
was the most relevant. Also BMP2/4, FGFR1 and barx1 showed the highest mean number
of positive cells in tuber maxillae. Barx1 was equally expressed in ramus mandibulae, but
BMP2/4 and FGFR1 mainly stained its posterior part cells. Apoptosis mostly affected ramus
mandibulae anterior part.
 Conclusions. We suggest about more active stimulation of bone growth in tuber max-
illa whereas ramus mandibulae. Apoptosis mainly affects ramus mandibulae anterior part
that possibly connects to the lower expression of growth stimulating factors and may indicate
lower bone remodelation ability.
Key words:  growth factors, apoptosis, orthognathic surgery, immunohistochemistry.
  SCIENTIFIC ARTICLES
  Stomatologija, Baltic Dental and Maxillofacial Journal, 9:40-46, 2007
1Department of Orthodontics, Institute of Stomatology, Riga Stradins
University, Latvia
2Institute of Anatomy and Anthropology, Riga Stradins University,
Latvia
2Department of Oral and Maxillofacial Surgery, Faculty of Den-
tistry, Riga Stradins University, Latvia
Iveta Jankovska1 – D.D.S.
Mara Pilmane2 – Dr. med., Dr. hab. med., Corresponding mem-
ber of Latvian Academy of Science, Director of
Institute of Anatomy and Anthropology
Ilga Urtane1 – D.D.S., Dr. med., Professor and Head of Department
of Orthodontics, Director of Institute of Stomatology
Andris Bigestans3 – M.D., D.D.S., lecturer
Girts Salms3 – M.D., D.D.S., lecturer
Gunars Lauskis3 – M.D., D.D.S., lecturer
Address correspondence to Dr. Iveta Jankovska, Department of
Orthodontics, Institute of Stomatology, Riga Stradins University,
20 Dzirciema Street, Riga, Latvia, LV 1007.
E-mail: iveta.j@one.lv
INTRODUCTION
Patients with severe dentofacial anomalies are
5-7 % in Latvian population around the age 18 [1].
These anomalies cause functional as well as estheti-
cal disorders and decrease life quality for person.  The
ethiopatogenesis of severe skeletal anomalies can be
genetically determined and/or linked with postnatal
develpoment. The treatment of severe dentofacial
anomalies is combined and related to environmental
mechanism of bone development. It does consist of
orthodontical procedures and orthognatic surgery, in-
cluding mainly osteotomies with movement of divided
jaw parts, fixation on right position, with following
long-term consolidation and remodeling process. How-
ever, even on modern technologies based treatment
can’t exclude relapses after orthognatic treatment.
Skeletal stability after orthognatic surgery depends
on many factors and clinical data show that relapses
differ individually without any clear seen origin. Ac-
cording to Mobarak et al. [2] relapse after jaw os-
teotomies is detected in around 10-30 % of cases.
The main relapse occurs in the first 6 months after
surgery. There may be mechanical and biological fac-
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tors substantial for relapse. Mechanical strain influ-
ences skeletal form via atrophic and hypertrophic
mechanism that is deemed bone remodeling. To un-
derstand the differential morphology and physiology
of craniofacial bones, it is essential to understand the
fundamental intrinsic and extrinsic factors that guide
growth, development and long-term maintenance. The
genome codes for three fundamental mechanisms in-
fluencing bone morphology: growth factors, vascular
induction and mechanically induced inflammation [3].
Essential role in bone remodeling play the growth
factors [4]. Growth factors are main signaling mol-
ecules for growth and development in ante– and post-
natal period. They are involved in cellular prolifera-
tion, differentiation and morphogenesis of tissues and
organs during embryogenesis, postnatal growth and
adulthood [5]. The effect of growth factors is medi-
ated through surface receptors (juxtacrine effects)
on the target cells by activating of intracellular phos-
phorylating enzymes that induce an intracellular sig-
naling pathway by aggregation of co-factors and other
to nuclei migrating proteins. Together with other tran-
scription factors they activate a set of genes, which
then exert the specific changes in cellular activity or
phenotype [6].
Transforming growth factor−β (TGF−β) belongs to
a large superfamily of related proteins that also includes
bone morphogenetic proteins (BMP), growth and dif-
ferentiation factors, activins and inhibins. During the
early stages of bone formation, the action of TGF−β is
to recruit and stimulate osteoprogenitor cells to prolifer-
ate, providing a pool of early osteoblasts [7]. Quite the
opposite, during later phases of osteoblast differentia-
tion, TGF−β blocks differentiation and mineralization [8].
Marchal Urist in the 1960’s was the first who
reported that protein extracted from demineralized
bone matrix were able to induce bone formation at
ectopic sites in rodents and the process initiated by
the implantation of these extracts closely resembled
the cellular progression seen during endochondral
bone formation and fracture healing [9]. Urist called
this bone-forming activity bone morphogenetic pro-
tein [10]. BMP passes the unique functions of induc-
ing the differentiation of cells in the osteoblastic lin-
eage, therefore is increasing the pool of mature cells
and enhances the differentiation function of the os-
teoblast [11; 12; 13; 14].
FGF (fibroblast growth factor) and FGFR (fibro-
blast growth factor receptors) play a critical role in
morphogenesis by regulating of cell proliferation,
differention and cell migration during embryonic de-
velopment. In adult organism FGF play an important
role in the control of the nervous system, in tissue
repair and wound healing [15].
Interesting, that influence of growth factors is
also regulated by different events, from which one of
most important is apoptosis [16; 4].
Expression of barx1 gene was observed in cran-
iofacial mesenchyme and could be associated with
skeletal hypoplasia in dentofacial region [17].
The aim of this article is present a progress re-
port of evaluation of TGF−β (transforming growth
factor−β), BMP2/4 (bone morphogenetic protein 2/
4), FGFR1 (fibroblast growth factor receptor one),
barx1 gene and apoptosis from tissue samples of oro-
maxillo-facial region in skeletal class III patients to
reveal possible morphopathogenesis of severe skel-
etal anomalies.
MATERIALS AND METHODS
Preliminary study group included 9 patients (5
females and 4 males) with severe skeletal class III
anomalies who needed combined orthodontic treat-
ment and orthognatic surgery.  The average age of
patients was 19.6 years. During orthognatic surgery
tissue samples were obtained from tuber maxillae,
ramus mandibulae anterior and posterior part and
gingiva from the lower jaw in region of second
molar.The samples were fixed in 2% formaldehyde
and 0.2% picric acid 0.1 M phosphate-buffer (pH
7.2). After they were washed in phosphate-buffered
saline for 12 hours, embedded in paraffin, and cut
into sections of 6-7 ìm thickness.  After
deparaffinization slides were stained with biotin-
streptavidin immunohistochemical (IMH) method [18]
for transforming growth factor−β (TGF−β, 1:100, RD
Systems, UK), bone morphogenetic protein 2/4
(BMP2/4, 1:100, RD Systems, UK), fibroblast growth
factor receptor 1 (FGFR1, 1:100, Cambridge Sci-
ence Park, UK) and barx1 gene (1:250, Cambridge
Science Park, UK).
TUNEL kit (Roche Diagnostics, Germany) was
used to detect apoptoticcells [19]. To get the overall
review we used the routine histological staining with
haematoxyline and eosine.
Counting of positive cells per 4 visual fields and
calculation of mean value and standard deviation per-
formed semi-quantative analysis of the slides. The
statistical evaluation of the findings was performed
with the help of SPSS for Windows 10.0 software.
The study protocol was approved by the ethics com-
mittee of Riga Stradins University.
RESULTS
In bone from ramus mandibulae anterior and
posterior part we detected osteones of different size,
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pressed barx1 (Fig. 6). Tuber maxillae osteocytes
expressed FGFR1 (Fig. 7) and also intensive expres-
sion of barx1 was detected in osteogenic and peri-
osteal cells (Fig. 8). Regional distribution of barx1
was seen also in ramus mandibulae anterior and
posterior parts (Fig.  9).
In tissue sample from tuber maxillae, ramus
mandibulae anterior and posterior part staining for
TGF−β was the most evident (122.25±8.220 cells/mm²,
93±11.401 cells/mm² and 69.5±12.503 cells/mm², re-
spectively; see Table; Fig.11). Also BMP2/4 showed
high mean number of positive cells in tuber maxillae
(65.5±17.233 cells/mm²) and ramus mandibulae pos-
terior part (43.25±6.625 cells/mm²), but less positive
cells expression was seen in ramus mandibulae an-
terior part (26±6.164 cells/mm²), see Fig. 12.
irregularly orientated cells and bone lamellae (Fig.
1). However, the bone from tuber maxillae seemed
even more chaotically organized with some circular
lamellar structures only in osteones (Fig. 2). Some
regions showed hyperplasia of connective tissue in
the Haversian channels. Blood vessels in soft tissue
close to such bone fragments and in periosteum were
with signs of sclerotization.
Osteocytes of ramus mandibulae anterior and
posterior part intensively expressed BMP 2/4, although
in posterior part of bone positive cells showed more
regional distribution than in anterior one (Figures 3,
4). Gingival epithelium above the affected bone re-
gions demonstrated hyperplasia of basal cells and
vacuolization of polymorphous epitheliocytes in su-
perficial layers (Fig. 5). Basal epithelial cells also ex-
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Fig. 2. Microphotograph of bone from tuber maxillae (hae-
matoxylin and eosine; x 250). Chaotically organized bone
structure
Fig. 1. Microphotograph of bone from ramus mandibulae
anterior part (haematoxylin and eosine; x 250). Irregular dis-
tribution of osteone structures
Fig. 3. Microphotograph of bone from ramus mandibulae
anterior part (immunohistochemical examination; x 250). Ex-
pression of BMP2/4
Fig. 4. Microphotograph of bone from ramus mandibulae
posterior part (immunohistochemical examination; x 250).
Expression of BMP2/4
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More FGFR1 expression also was observed in
tissue sample from tuber maxillae (44.25±15.217
cells/mm²) and ramus mandibulae posterior part
(28.25±13.301 cells/mm²) compared with ramus
mandibulae anterior part (18.25±3.593 cells/mm²),
see Fig. 13. In skeletal class III patient ramus
mandibulae anterior part was noticed the large
amount of apoptotic cells (44.75±.852 cells/mm²) that
decreases in tuber maxillae and ramus mandibulae
posterior part (28.25±3.403 and 21±9.933 cells/mm²;
Fig. 10). Barx1 gene expression was highest in tis-
sue sample from tuber maxillae (22.75±6.5 cells/
Fig. 5. Microphotograph of oral mucosa from region of lower
second molar (haematoxylin and eosine; x 400). Hyperplasia in
basal epithelial cells and vacuolization in more superficial layer
Table. Mean numbers and standard deviation (SD) of TGF-β, BMP2/4, FGFR-1, TUNEL and barx1 positive cells in bone of
orthognatic surgery skeletal class III patients
            Factors 
Place 








Tuber maxilla 122.25±8.220 65.5±17.233 44.25±15.217 28.25±3.403 22.75±6.5 
Ramus mandibulae 
anterior part 93±11.401 26±6.164 18.25±3.593 44.75±5.852 6±1.154 
Ramus mandibulae 
posterior part 69.5±12.503 43.25±6.625 28.25±13.301  21±9.933 6.75±4.856 
 
Fig. 6. Microphotograph of oral mucosa from region of lower
second molar (immunohistochemical examination; x 250). Ex-
pression of barx1 gene
Fig. 7. Microphotograph of bone from tuber maxillae (immu-
nohistochemical examination; x 250). Expression of FGFR1
Fig. 8. Microphotograph of bone from tuber maxillae (immu-
nohistochemical examination; x 250). Expression of barx1 gene
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mm²) while ramus mandibulae anterior and poste-
rior part showed almost equal mean numbers of posi-
tive cells (6±1.154 and 6.75±4.856 cells/mm²), see
Fig. 14.
There were statistically significant differences
between mean numbers of growth factors, barx1 con-
taining and apoptotic cells in tuber maxillae, ramus
mandibulae anterior and posterior part.
DISCUSSION
Preliminary results from this study suggest that
bones from various sites in maxilla and mandible show
different expression of growth factors, barx1 gene
and apoptotic cells. There is almost no data about
TGF−β, BMP2/4, FGFR1, barx1 and apoptotic cells
distribution in orthognathic surgery patients in the
scientific literature.
 In all tissue samples TGF−β was seen to bee
most evident, possibly because this protein belongs
to TGF−β superfamily that includes TGF−β them-
selves, activins and BMP. BMP 2/4 showed high
level in tissue samples from ramus mandibulae
anterior and posterior part as well as in tuber
maxillae that par tially support the data of
Suttapreyasri et al. [4]. However most part of
studies have reported just appearance of BMP in
distraction osteogenesis and thus concluded that
BMP enhance bone regeneration and remodeling
[20; 21; 22; 23; 24].
FGFR1 was seen in smaller amount when com-
pared with BMP2/4 in tuber maxillae and ramus
Fig. 9. Microphotograph of bone from ramus mandibulae
anterior part (immunohistochemical examination; x 250). Ex-
pression of barx1 gene
Fig. 10. Microphotograph of bone from ramus mandibulae
posterior part (TUNEL method; x 250). Expression of
apoptotic cells
Fig. 11. Microphotograph of bone from ramus mandibulae
anterior part (immunohistochemical examination; x 400). Ex-
pression of TGF-β
Fig. 12. Comparison of mean numbers in TGF-β, BMP 2/4,
FGFR 1, barx1 and apoptotic cells (TUNEL) in tissue sam-
ples from tuber maxillae
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mandibulae posterior part, but almost equally in
samples from ramus mandibulae anterior part of our
patients. This growth factor is highly expressed in
bone and cartilage of adult patients and plays an im-
portant role in hard tissue repair and regeneration
process [15].
We used TUNEL method to detect apoptotic cells
and this method is very effective at identifying nuclear
DNA fragmentation associated with apoptosis [19].
In ramus mandibulae anterior part apoptotic cells
were more observed than such expressing BMP2/4
and FGFR1 in the same tissues sample. That’s mean
that resorbtion of bone in this region may be more
active than new bone formation.
 Indistinct expression of barx1 [17] in all jaw
sites seems to correlate with more distinct postnatal
supportive tissue growth processes in jaw in cases of
already appeared dentofacial anomalies, that does not
need more mesenchyme stimulation.
Fig. 14. Comparison of mean numbers in TGF-β, BMP 2/4,
FGFR 1, barx1 and apoptotic cells (TUNEL) in tissue sam-
ples from ramus mandibulae posterior part
Fig. 13. Comparison of mean numbers in TGF-β, BMP 2/4,
FGFR 1, barx1 and apoptotic cells (TUNEL) in tissue sam-
ples from ramus mandibulae anterior part
 Concerning to our study it is envisaged that the re-
sults overall would lead to a better understanding of bone
morphogenesis and remodeling potential at cellular,
molecular and genetic level, so that clinically effective
treatment strategies could be developed in future for
patients with dentofacial anomalies and deformities.
CONCLUSIONS
In skeletal class III anomalies expression of
growth factors and bone growth stimulating genes
the highest is in tuber maxillae. Growing centers of
ramus mandibulae possess equal barx1 expression,
while FGFR1 and BMP2/4 mainly stimulate ramus
mandibulae posterior part, and TGF−β – its anterior
part. Apoptosis mainly affects ramus mandibulae
anterior part that possibly connects to the lower ex-
pression of growth stimulating factors and may indi-
cate lower bone remodelation ability.
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